SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TMP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GMK_D_DVAD8_0 (GRAMICIDIN A) |
4xr9 | CALS8 (Micromonosporaechinospora) | 3 / 3 | TRP A 223VAL A 229TRP A 224 | NoneTMP A 503 (-4.4A)None | 1.42A | 1gmkC-4xr9A:undetectable1gmkD-4xr9A:undetectable | 1gmkC-4xr9A:5.361gmkD-4xr9A:5.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_A_GA2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 11 | HIS A 58GLU A 83ILE A 100TYR A 101GLN A 125MET A 128ARG A 163TYR A 172ARG A 176GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.5A) | 0.68A | 1ki2A-1vtkA:47.4 | 1ki2A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_A_GA2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 11 | HIS A 58ILE A 97TYR A 101MET A 85ARG A 163 | TMP A 500 (-3.8A)TMP A 500 ( 4.5A)TMP A 500 (-4.5A)NoneTMP A 500 (-3.3A) | 1.45A | 1ki2A-1vtkA:47.4 | 1ki2A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_A_GA2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 11 | HIS A 58ILE A 100TYR A 101GLN A 125MET A 128ARG A 163TYR A 172ARG A 176ARG A 222GLU A 225 | TMP A 500 (-3.8A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.60A | 1ki2A-1vtkA:47.4 | 1ki2A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_B_GA2B2_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 12 / 12 | HIS A 58GLU A 83TRP A 88ILE A 100TYR A 101GLN A 125MET A 128ARG A 163TYR A 172ARG A 176ARG A 222GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.69A | 1ki2B-1vtkA:48.2 | 1ki2B-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_B_GA2B2_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | HIS A 58ILE A 97TYR A 101MET A 85ARG A 163 | TMP A 500 (-3.8A)TMP A 500 ( 4.5A)TMP A 500 (-4.5A)NoneTMP A 500 (-3.3A) | 1.41A | 1ki2B-1vtkA:48.2 | 1ki2B-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 12 | GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101MET A 128TYR A 172ARG A 176ARG A 222GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.79A | 1ki3A-1vtkA:47.5 | 1ki3A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | HIS A 58GLN A 125TYR A 172ARG A 176ARG A 220 | TMP A 500 (-3.8A)TMP A 500 (-3.0A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.4A) | 1.41A | 1ki3A-1vtkA:47.5 | 1ki3A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101MET A 128TYR A 172ARG A 176GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.5A) | 0.67A | 1ki3A-1vtkA:47.5 | 1ki3A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 12 | HIS A 58TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128TYR A 172ARG A 176GLU A 225 | TMP A 500 (-3.8A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.5A) | 0.73A | 1ki3A-1vtkA:47.5 | 1ki3A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 10 / 12 | TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128TYR A 172ARG A 176ARG A 222GLU A 225 | NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.80A | 1ki3A-1vtkA:47.5 | 1ki3A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_B_PE2B2_1 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 12 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101MET A 121GLN A 125MET A 128TYR A 172ARG A 176GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)NoneTMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.5A) | 0.55A | 1ki3B-1vtkA:47.7 | 1ki3B-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128ALA A 168TYR A 172GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.5A)TMP A 500 (-3.7A)TMP A 500 (-3.5A) | 0.38A | 1ki7A-1vtkA:47.4 | 1ki7A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 6 / 12 | HIS A 58ILE A 97TYR A 101ALA A 167ARG A 222GLU A 225 | TMP A 500 (-3.8A)TMP A 500 ( 4.5A)TMP A 500 (-4.5A)TMP A 500 ( 4.2A)TMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.94A | 1ki7A-1vtkA:47.4 | 1ki7A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128ALA A 168TYR A 172ARG A 222GLU A 225 | TMP A 500 (-3.8A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.5A)TMP A 500 (-3.7A)TMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.37A | 1ki7A-1vtkA:47.4 | 1ki7A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 12 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100GLN A 125MET A 128ARG A 163ALA A 168TYR A 172ARG A 222GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.5A)TMP A 500 (-3.7A)TMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.56A | 1ki7B-1vtkA:48.6 | 1ki7B-1vtkA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MAA_A_DMEA998_1 (ACETYLCHOLINESTERASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | ASP A 55GLY A 59GLU A 225TYR A 172TYR A 239 | NoneADP A 400 (-3.2A)TMP A 500 (-3.5A)TMP A 500 (-3.7A)None | 1.24A | 1maaA-1vtkA:undetectable | 1maaA-1vtkA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P5Z_B_AR3B304_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 1.14A | 1p5zB-1vtkA:16.5 | 1p5zB-1vtkA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TUV_A_VK3A4558_1 (PROTEIN YGIN) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 4 / 7 | TYR A 101GLU A 225LEU A 232TYR A 172 | TMP A 500 (-4.5A)TMP A 500 (-3.5A)NoneTMP A 500 (-3.7A) | 1.10A | 1tuvA-1vtkA:undetectable | 1tuvA-1vtkA:15.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC1383_1 (CES1 PROTEIN) |
4xr9 | CALS8 (Micromonosporaechinospora) | 4 / 5 | TRP A 282PRO A 281LEU A 277GLY A 273 | NoneNoneTMP A 503 (-4.6A)TMP A 503 (-3.7A) | 1.32A | 1ya4C-4xr9A:undetectable | 1ya4C-4xr9A:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A7Q_A_CFBA328_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 1.13A | 2a7qA-1vtkA:16.6 | 2a7qA-1vtkA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A7Q_A_CFBA328_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TYR A 101GLN A 125ARG A 163GLU A 225 | TMP A 500 (-2.7A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.20A | 2a7qA-1vtkA:16.6 | 2a7qA-1vtkA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AVD_B_SAMB601_0 (CATECHOL-O-METHYLTRANSFERASE) |
4xr9 | CALS8 (Micromonosporaechinospora) | 5 / 12 | MET A 431GLY A 336ALA A 372ALA A 338ARG A 430 | NoneNoneNoneNoneTMP A 503 (-3.2A) | 1.37A | 2avdB-4xr9A:4.7 | 2avdB-4xr9A:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_A_AZZA1211_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 10 | GLU A 83TRP A 88GLN A 125ARG A 163ALA A 168 | TMP A 500 (-2.7A)NoneTMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.04A | 2jj8A-1vtkA:13.5 | 2jj8A-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_B_AZZB1211_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 6 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125ARG A 163ALA A 168 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.07A | 2jj8B-1vtkA:13.9 | 2jj8B-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_C_AZZC1211_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88GLN A 125ARG A 163ALA A 168 | TMP A 500 (-2.7A)NoneTMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.03A | 2jj8C-1vtkA:13.3 | 2jj8C-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_D_AZZD1211_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 10 | GLU A 83TRP A 88GLN A 125ARG A 163ALA A 168 | TMP A 500 (-2.7A)NoneTMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.03A | 2jj8D-1vtkA:14.0 | 2jj8D-1vtkA:22.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_A_AC2A1_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | HIS A 58GLN A 125TYR A 172ARG A 176ARG A 220 | TMP A 500 (-3.8A)TMP A 500 (-3.0A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.4A) | 1.44A | 2ki5A-1vtkA:47.2 | 2ki5A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_A_AC2A1_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101MET A 128TYR A 172ARG A 176ARG A 222GLU A 225 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.78A | 2ki5A-1vtkA:47.2 | 2ki5A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_A_AC2A1_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128TYR A 172ARG A 176ARG A 222GLU A 225 | TMP A 500 (-3.8A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A)TMP A 500 (-3.5A) | 0.63A | 2ki5A-1vtkA:47.2 | 2ki5A-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_B_AC2B2_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58GLU A 83TRP A 88ILE A 97ILE A 100TYR A 101MET A 128ARG A 163TYR A 172ARG A 176ARG A 222 | TMP A 500 (-3.8A)TMP A 500 (-2.7A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A) | 0.73A | 2ki5B-1vtkA:48.2 | 2ki5B-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_B_AC2B2_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | HIS A 58ILE A 97TYR A 101MET A 85ARG A 163 | TMP A 500 (-3.8A)TMP A 500 ( 4.5A)TMP A 500 (-4.5A)NoneTMP A 500 (-3.3A) | 1.43A | 2ki5B-1vtkA:48.2 | 2ki5B-1vtkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KI5_B_AC2B2_1 (PROTEIN (THYMIDINEKINASE)) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 11 / 12 | HIS A 58TRP A 88ILE A 97ILE A 100TYR A 101GLN A 125MET A 128ARG A 163TYR A 172ARG A 176ARG A 222 | TMP A 500 (-3.8A)NoneTMP A 500 ( 4.5A)TMP A 500 ( 4.1A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.6A)TMP A 500 (-3.3A)TMP A 500 (-3.7A)NoneTMP A 500 (-3.2A) | 0.54A | 2ki5B-1vtkA:48.2 | 2ki5B-1vtkA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UXO_B_TACB1211_1 (HTH-TYPETRANSCRIPTIONALREGULATOR TTGR) |
3lv8 | THYMIDYLATE KINASE (Vibriocholerae) | 5 / 11 | LEU A 70LEU A 63LEU A 121ILE A 157ILE A 113 | NoneNoneNoneTMP A 214 (-3.3A)None | 1.21A | 2uxoB-3lv8A:undetectable | 2uxoB-3lv8A:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_A_GEOA1210_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101ARG A 163ALA A 168 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.09A | 2vppA-1vtkA:14.9 | 2vppA-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_A_GEOA1210_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | TRP A 88TYR A 101GLN A 125ARG A 163ALA A 168 | NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 0.98A | 2vppA-1vtkA:14.9 | 2vppA-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_B_GEOB1207_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125ARG A 163 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A) | 0.98A | 2vppB-1vtkA:14.3 | 2vppB-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_B_GEOB1207_1 (DEOXYNUCLEOSIDEKINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TYR A 101GLN A 125ARG A 163ALA A 168 | TMP A 500 (-2.7A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 0.95A | 2vppB-1vtkA:14.3 | 2vppB-1vtkA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZI9_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 1.11A | 2zi9A-1vtkA:15.3 | 2zi9A-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZI9_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TYR A 101GLN A 125ARG A 163GLU A 225 | TMP A 500 (-2.7A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.19A | 2zi9A-1vtkA:15.3 | 2zi9A-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZI9_B_CL9B401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88GLN A 125ARG A 220GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-3.0A)TMP A 500 (-3.4A)TMP A 500 (-3.5A) | 1.27A | 2zi9B-1vtkA:16.5 | 2zi9B-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZI9_B_CL9B401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 1.02A | 2zi9B-1vtkA:16.5 | 2zi9B-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 0.95A | 2ziaA-1vtkA:17.2 | 2ziaA-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TYR A 101GLN A 125ARG A 163GLU A 225 | TMP A 500 (-2.7A)TMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.3A)TMP A 500 (-3.5A) | 1.01A | 2ziaA-1vtkA:17.2 | 2ziaA-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_B_CL9B401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101GLN A 125GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 (-3.5A) | 1.00A | 2ziaB-1vtkA:16.7 | 2ziaB-1vtkA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3APW_B_DP0B190_1 (ALPHA-1-ACIDGLYCOPROTEIN 2) |
5uiv | BIFUNCTIONALTHYMIDYLATE/URIDYLATE KINASE (Candidaalbicans) | 5 / 12 | LEU A 51GLU A 159ARG A 39SER A 96TYR A 100 | TMP A 301 (-4.5A)TMP A 301 ( 4.5A)TMP A 301 (-3.9A)TMP A 301 ( 4.7A)TMP A 301 (-3.6A) | 1.42A | 3apwB-5uivA:undetectable | 3apwB-5uivA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HP1_A_LLTA401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | GLU A 83TRP A 88TYR A 101ALA A 167GLU A 225 | TMP A 500 (-2.7A)NoneTMP A 500 (-4.5A)TMP A 500 ( 4.2A)TMP A 500 (-3.5A) | 1.05A | 3hp1A-1vtkA:16.7 | 3hp1A-1vtkA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HP1_A_LLTA401_1 (DEOXYCYTIDINE KINASE) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | TRP A 88TYR A 101GLN A 125ALA A 167GLU A 225 | NoneTMP A 500 (-4.5A)TMP A 500 (-3.0A)TMP A 500 ( 4.2A)TMP A 500 (-3.5A) | 1.22A | 3hp1A-1vtkA:16.7 | 3hp1A-1vtkA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KPD_B_SAMB1000_1 (UNCHARACTERIZEDPROTEIN MJ0100) |
5uiv | BIFUNCTIONALTHYMIDYLATE/URIDYLATE KINASE (Candidaalbicans) | 3 / 3 | ASN A 53ASN A 48GLU A 159 | NoneNoneTMP A 301 ( 4.5A) | 0.69A | 3kpdC-5uivA:undetectable | 3kpdC-5uivA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KPD_C_SAMC1000_0 (UNCHARACTERIZEDPROTEIN MJ0100) |
5uiv | BIFUNCTIONALTHYMIDYLATE/URIDYLATE KINASE (Candidaalbicans) | 3 / 3 | ASN A 53ASN A 48GLU A 159 | NoneNoneTMP A 301 ( 4.5A) | 0.82A | 3kpdB-5uivA:undetectable | 3kpdB-5uivA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QL6_A_NIMA614_1 (LACTOPEROXIDASE) |
5uiv | BIFUNCTIONALTHYMIDYLATE/URIDYLATE KINASE (Candidaalbicans) | 4 / 7 | GLU A 159ARG A 160PHE A 67PRO A 37 | TMP A 301 ( 4.5A)NoneTMP A 301 (-3.1A)TMP A 301 ( 4.4A) | 1.32A | 3ql6A-5uivA:undetectable | 3ql6A-5uivA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_C_RTZC1_1 (CYTOCHROME P450 2D6) |
3lv8 | THYMIDYLATE KINASE (Vibriocholerae) | 5 / 12 | GLY A 10LEU A 11GLU A 12SER A 102PHE A 165 | NoneNoneTYD A 215 (-2.8A)TMP A 214 ( 4.2A)None | 1.29A | 3tbgC-3lv8A:undetectable | 3tbgC-3lv8A:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKV_B_AERB601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
2ido | DNA POLYMERASE IIIEPSILON SUBUNIT (Escherichiacoli) | 4 / 5 | ARG A 159ASP A 12GLU A 173VAL A 38 | TMP A2001 ( 4.6A) MN A1001 (-2.6A)NoneNone | 1.39A | 4nkvB-2idoA:undetectable | 4nkvB-2idoA:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KMF_A_6U9A1301_1 (ION TRANSPORTPROTEIN) |
2ido | DNA POLYMERASE IIIEPSILON SUBUNIT (Escherichiacoli) | 4 / 6 | GLY A 64GLU A 61PHE A 63ILE A 31 | NoneTMP A2001 (-4.0A)NoneNone | 0.96A | 5kmfA-2idoA:undetectable5kmfC-2idoA:undetectable | 5kmfA-2idoA:19.595kmfC-2idoA:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_F_CVIF301_1 (REGULATORY PROTEINTETR) |
3lv8 | THYMIDYLATE KINASE (Vibriocholerae) | 4 / 8 | ILE A 157ARG A 156VAL A 72ASP A 65 | TMP A 214 (-3.3A)NoneTYD A 215 (-4.1A) CL A 222 ( 4.7A) | 1.10A | 5vlmF-3lv8A:1.4 | 5vlmF-3lv8A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZW4_A_SAMA302_0 (PUTATIVEO-METHYLTRANSFERASEYRRM) |
1vtk | THYMIDINE KINASE (Humanalphaherpesvirus1) | 5 / 12 | PRO A 195GLY A 129ALA A 133ALA A 168ALA A 167 | NoneNoneNoneTMP A 500 (-3.5A)TMP A 500 ( 4.2A) | 0.82A | 5zw4A-1vtkA:undetectable | 5zw4A-1vtkA:22.09 |